Dr. Keith Michael Cavaness, DO

Dr. Cavaness practices at Enloe Health in Chico, California, part of Enloe Health.

Dr. Cavaness' NPI, 1679695068, was assigned on April 4, 2007. Dr. Cavaness graduated from Touro University California - Vallejo in 2003. Dr. Cavaness holds Texas license P0018.

Dr. Cavaness' primary practice is Enloe Health, at 1531 Esplanade, Chico, CA 95926 in Butte County. The practice phone is (530) 332-7300.

Dr. Cavaness' primary practice is Enloe Health in Chico, California, part of Enloe Health. The medical group on file is Chico Hospitalist Group. Dmand AI also links Dr. Cavaness to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cavaness practices. Vendor and product names are available with a free account.

Surgery is Dr. Cavaness' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Cavaness is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Cavaness' licenses on file in 2 states: Texas and Michigan.

Dmand AI lists abdominal adhesion surgery and colon removal among the conditions Dr. Cavaness treats.

CMS data shows 364 Medicare services from Dr. Cavaness across 5 procedure codes in 2024, for 247 Medicare patients. Medicare paid $36,794 for them.

CMS counts 247 Medicare patients who saw Dr. Cavaness in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cavaness' median patient age at 71, with 51% women.

In 2024, Dr. Cavaness wrote 78 Medicare Part D claims for 53 patients. 99% of them were for generic drugs. CMS names the drug for 46 of them, across 2 drugs with 11 or more claims each, at $157 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Cavaness for performance year 2024, reported as part of a group. Dr. Cavaness accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cavaness as offering telehealth.

Coronary artery bypass graft (CABG): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Cavaness, published from 2010 to 2020. The most frequent topics are Carcinoma, Hepatocellular, Hepatectomy and Liver Neoplasms. Dr. Cavaness' most frequent co-authors are Goran B. G. Klintmalm, MD, William R. Jarnagin, MD and Robert M. Goldstein, MD.

Dmand AI links Dr. Cavaness to 2 clinical trials. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases. Baylor Research Institute sponsors the most, 2.

CMS Open Payments shows 54 general payments to Dr. Cavaness from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Intuitive Surgical, Inc. paid the most, $2,135.

Dr. Cavaness graduated from Touro University California - Vallejo in 2003.

Dr. Cavaness is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.